Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




May
15
Today In Oncology
Atezolizumab/Cabozantinib vs Docetaxel in Previously Treated Metastatic NSCLC
Study Reveals Potential Overtreatment of DCIS in Older Women With Limited Life Expectancy
T-DXd for Advanced Solid Tumors With Activating HER2 Mutations
Childhood Cancer Survivors Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus
Childrens Cancer Cause Opens Applications for the 2024 Survivorship Champions Prize
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside